Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Erba Diagnostics Inc (ERB)

Erba Diagnostics Inc (ERB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
ERBA Diagnostics, Inc. develops, manufactures and markets diagnostic test kits, or assays, and automated systems primarily for autoimmune and infectious diseases. The main subsidiaries of the company include: Diamedix Corporation, Delta Biologicals S.r.l. and ImmunoVision, Inc. ERBA Diagnostics, Inc., formerly known as IVAX Diagnostics, Inc., is headquartered in Miami, Florida.
(Values in U.S. Thousands) Sep, 2016 Jun, 2016 Mar, 2016 Dec, 2015 Sep, 2015
Sales -9,999,000 -9,999,000 -9,999,000 -9,999,000 -9,999,000
Sales Growth unch unch unch unch -168,150.42%
Net Income -9,999,000 -9,999,000 -9,999,000 -9,999,000 -9,999,000
Net Income Growth unch unch unch unch -1,817,900.00%
(Values in U.S. Thousands) Sep, 2016 Jun, 2016 Mar, 2016 Dec, 2015 Sep, 2015
Total Assets -9,999,000 -9,999,000 -9,999,000 -9,999,000 -9,999,000
Total Assets Growth unch unch unch unch -38,915.99%
Total Liabilities -9,999,000 -9,999,000 -9,999,000 -9,999,000 -9,999,000
Total Liabilities Growth unch unch unch unch -107,847.84%
(Values in U.S. Thousands) Sep, 2016 Jun, 2016 Mar, 2016 Dec, 2015 Sep, 2015
Operating Cash Flow -9,999,000 -9,999,000 -9,999,000 -9,999,000 -9,999,000
Operating Cash Flow Growth unch unch unch unch -462,816.67%
Net Cash Flow -9,999,000 -9,999,000 -9,999,000 -9,999,000 -9,999,000
Change in Net Cash Flow unch unch unch unch -1,052,427.42%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar